Advanced prostate cancer cases are rising worldwide as fewer men undergo routine PSA screening and early symptoms go ...

Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...

Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published ...

Q. You recently wrote that testosterone does not increase the risks for heart attacks. But you overlooked the real risk of testosterone therapy: cancer!

Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...

Prostate cancer has overtaken breast cancer to become the most common form of the disease in the UK for the first time.

New report shows growing use of medications, such as chemotherapy, immunotherapy, and hormone therapy, given before surgery ...

OBD’s proprietary EpiSwitch ® platform harnesses 3D genomic regulation biomarkers to develop molecular diagnostic classifiers for numerous indications, including predicting response to therapy, ...

The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a ...